I was going through the pile of old ( carcuss strewn)ResApp deals of the past- and my enthusiatic take during Sanofi days- one thing which really stood out; ResApp being used as a monitoring tool in Trials.
"If you dig deeper, Sanofi's collaborated with Science 37 for virtual trials, instead of getting the trial subjects to the location, to trial in Real World setting. I won't be surprised if they integrate Resapp algo into Science 37 to conduct trials in home setting . This also adheres well with FDA's Real World Evidence ( RWE) programs where they look favorably into companies which can prove their drug is suitable in Real world setting."
Though the deal did'nt eventuate, what came out good is the learnings and also enhanced the bussiness cases of ResApp-DX alogorithms not plataeuing to only Telehealth settings but rising to new heights of being used in high profile drug trials......
I was worried that we could be lost in the pile of other apps due to pronlonged period of silence, but what is slowing emerging is that we are indeed in a cluster, only a STAR studded one!
Moral: What seemed to be a delerious past is actually a new strong step to the future.
IMO
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Grants Option to Consumer Health Division of Sanofi
Ann: ResApp Grants Option to Consumer Health Division of Sanofi, page-264
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online